Changing trends in penile prosthesis implantation in China and an overview of postoperative outcomes from a single center.

IF 2.4 3区 医学 Q2 ANDROLOGY
Chenwang Zhang, Haowei Bai, Chenkun Shi, Huirong Chen, Peng Li, Yuhua Huang, Huixing Chen, Fujun Zhao, Chencheng Yao, Zheng Li, Erlei Zhi
{"title":"Changing trends in penile prosthesis implantation in China and an overview of postoperative outcomes from a single center.","authors":"Chenwang Zhang, Haowei Bai, Chenkun Shi, Huirong Chen, Peng Li, Yuhua Huang, Huixing Chen, Fujun Zhao, Chencheng Yao, Zheng Li, Erlei Zhi","doi":"10.1186/s12610-024-00228-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Surgical penile prosthesis implantation (PPI) procedures have only recently been introduced to mainland China, with the overall number of such procedures having been conducted to date remaining relatively low. Accordingly, relatively little remains known with respect to the annual trends in PPI. Accordingly, this study was developed with the goal of clarifying these trends across different hospitals in mainland China, while also providing a single-center overview of post-PPI patient outcomes.</p><p><strong>Results: </strong>To identify males in mainland China who had undergone PPI, a retrospective review of data from January 2019 - October 2023 was conducted. This approach revealed an increase in the total PPI caseload from 120 in 2019 to 413 within the first 10 months of 2023. Over this same interval, the number of surgeons performing PPI rose from 33 to 74. A retrospective review of the 112 patients who had undergone PPI at Shanghai General Hospital from 2019-2023 revealed that these patients had a median age of 39 [27-63] years, and PPI treatment led to a significant increase in median International Index of Erectile Function-5 (IIEF-5) scores from a baseline value of 10.23 ± 1.26 to a post-treatment value of 22.6 ± 2.73. The underlying causes of erectile dysfunction for these patients included vasculogenic factors (58/112; 51.8%), diabetes mellitus (21/112; 18.8%), and injuries to the spinal cord or pelvis (14/112; 12.5%). The overall rates of satisfaction with the PPI reported by patients and their partners were 93.0% and 90.4%, respectively, and the 3-year PPI survival rate for this cohort was 87%.</p><p><strong>Conclusion: </strong>These data highlight a rising trend in the number of PPI being performed in China, with these steadily increasing rates since 2019 emphasizing the increasingly high levels of acceptance of this procedure by patients and clinicians as a means of treating erectile dysfunction. However, the expertise is restricted to a small number of surgeons. Even so, it is a safe and efficacious approach to managing severe erectile dysfunction for patients in China, and when performed by experienced surgeons based on standardized protocols, low complication rates can be achieved while providing patients and their sexual partners with high levels of satisfaction.</p>","PeriodicalId":8730,"journal":{"name":"Basic and Clinical Andrology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11311907/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic and Clinical Andrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12610-024-00228-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Surgical penile prosthesis implantation (PPI) procedures have only recently been introduced to mainland China, with the overall number of such procedures having been conducted to date remaining relatively low. Accordingly, relatively little remains known with respect to the annual trends in PPI. Accordingly, this study was developed with the goal of clarifying these trends across different hospitals in mainland China, while also providing a single-center overview of post-PPI patient outcomes.

Results: To identify males in mainland China who had undergone PPI, a retrospective review of data from January 2019 - October 2023 was conducted. This approach revealed an increase in the total PPI caseload from 120 in 2019 to 413 within the first 10 months of 2023. Over this same interval, the number of surgeons performing PPI rose from 33 to 74. A retrospective review of the 112 patients who had undergone PPI at Shanghai General Hospital from 2019-2023 revealed that these patients had a median age of 39 [27-63] years, and PPI treatment led to a significant increase in median International Index of Erectile Function-5 (IIEF-5) scores from a baseline value of 10.23 ± 1.26 to a post-treatment value of 22.6 ± 2.73. The underlying causes of erectile dysfunction for these patients included vasculogenic factors (58/112; 51.8%), diabetes mellitus (21/112; 18.8%), and injuries to the spinal cord or pelvis (14/112; 12.5%). The overall rates of satisfaction with the PPI reported by patients and their partners were 93.0% and 90.4%, respectively, and the 3-year PPI survival rate for this cohort was 87%.

Conclusion: These data highlight a rising trend in the number of PPI being performed in China, with these steadily increasing rates since 2019 emphasizing the increasingly high levels of acceptance of this procedure by patients and clinicians as a means of treating erectile dysfunction. However, the expertise is restricted to a small number of surgeons. Even so, it is a safe and efficacious approach to managing severe erectile dysfunction for patients in China, and when performed by experienced surgeons based on standardized protocols, low complication rates can be achieved while providing patients and their sexual partners with high levels of satisfaction.

中国阴茎假体植入术的变化趋势和单个中心的术后效果概述。
背景:阴茎假体植入手术(PPI)最近才被引入中国大陆,迄今为止,此类手术的总体数量仍然相对较少。因此,人们对 PPI 的年度趋势知之甚少。因此,本研究旨在明确中国大陆不同医院的趋势,同时提供单中心的 PPI 术后患者预后概况:为了确定中国大陆接受过 PPI 的男性,我们对 2019 年 1 月至 2023 年 10 月的数据进行了回顾性审查。该方法显示,PPI病例总数从2019年的120例增加到2023年前10个月的413例。在同一时间段内,实施 PPI 的外科医生人数从 33 人增加到 74 人。对2019年至2023年期间在上海总医院接受PPI治疗的112名患者进行回顾性回顾后发现,这些患者的中位年龄为39[27-63]岁,PPI治疗使国际勃起功能指数-5(IIEF-5)评分的中位数从基线值(10.23±1.26)分显著上升至治疗后的(22.6±2.73)分。这些患者勃起功能障碍的根本原因包括血管致病因素(58/112;51.8%)、糖尿病(21/112;18.8%)以及脊髓或骨盆损伤(14/112;12.5%)。患者及其伴侣对PPI的总体满意率分别为93.0%和90.4%,该组群的3年PPI存活率为87%:这些数据凸显了中国实施 PPI 的数量呈上升趋势,自 2019 年以来,PPI 的实施率稳步上升,强调了患者和临床医生对该手术作为治疗勃起功能障碍手段的接受程度越来越高。然而,这方面的专业知识仅限于少数外科医生。即便如此,对于中国的重度勃起功能障碍患者来说,这是一种安全有效的治疗方法,如果由经验丰富的外科医生根据标准化方案实施,可以实现较低的并发症发生率,同时为患者及其性伴侣提供较高的满意度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Basic and Clinical Andrology
Basic and Clinical Andrology Medicine-Urology
CiteScore
3.50
自引率
0.00%
发文量
21
审稿时长
22 weeks
期刊介绍: Basic and Clinical Andrology is an open access journal in the domain of andrology covering all aspects of male reproductive and sexual health in both human and animal models. The journal aims to bring to light the various clinical advancements and research developments in andrology from the international community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信